Acetaminophen (ACE) Rapid Test Device

Acetaminophen, also called paracetamol, is a non-opioid pain reliever and fever reducer. It is known by different names globally. In many countries, acetaminophen is commonly called paracetamol. Other names include APAP and N-acetyl-para-aminophenol. The chemical identity of acetaminophen is commonly listed with molecular formula C8H9NO2, PubChem CID 1983, and CAS number 103-90-2.

The Acetaminophen (ACE) Rapid Test Device is used for preliminary qualitative screening of acetaminophen in urine. In clinical and toxicology settings, acetaminophen testing may support drug monitoring, emergency evaluation, medication exposure assessment, and laboratory screening workflows.

Applications

• Hospital toxicology screening
• Emergency care support
• Clinical drug monitoring workflows
• Rehabilitation and de-addiction centers
• Occupational health screening programs
• Laboratory-based urine testing
• Preliminary drug exposure assessment
• Professional diagnostic and institutional testing programs

• Acetaminophen is available in many prescription and non-prescription products. Because multiple medicines may contain acetaminophen, accidental overexposure may occur when products are used together without proper awareness.
• The Acetaminophen rapid test device can be useful in professional environments where acetaminophen exposure needs to be screened quickly.
• The test may help support clinical decision-making, but final interpretation should always be based on patient history, clinical condition, laboratory policy, and confirmatory testing when required.

The Acetaminophen (ACE) Rapid Test Device uses a rapid test format for urine specimens. The test is designed to provide a qualitative screening result at the stated 500 ng/mL cut-off.

Benefits

• Urine-based rapid screening format
• 500 ng/mL cut-off level
• Designed for acetaminophen / ACE detection
• Supports toxicology and drug monitoring workflows
• Suitable for professional laboratory use
• Fast preliminary screening support
• Useful for hospitals, clinics, and diagnostic centers
• Designed for international healthcare markets

The Acetaminophen (ACE) Rapid Test Device is designed for urine specimens. Urine is commonly used in toxicology screening because it is convenient for drug and metabolite detection workflows.

Guidance

• Use urine specimens only
• Use clean sample collection procedures
• Follow the product insert carefully
• Treat all urine samples as potentially biohazardous
• Interpret results within the stated reading window
• Use confirmatory testing where required by clinical, legal, or institutional policy

Note

A rapid test result should be considered preliminary unless confirmed by a validated laboratory method where required.

Steps

• Bring the test device and urine specimen to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect urine using a clean sample collection procedure
• Apply the urine specimen according to the product insert
• Wait for the test reaction to complete within the instructed time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Acetaminophen (ACE) Rapid Test Device.

Positive

A positive result suggests that acetaminophen may be present in the urine specimen at or above the stated cut-off. Positive results are preliminary unless confirmed by an appropriate laboratory method.

Negative

A negative result suggests that acetaminophen was not detected or was below the test cut-off at the time of testing. A negative result does not replace clinical judgment.

Invalid

If the control indicator does not appear, the result is invalid. The test should be repeated with a new device and fresh urine specimen according to the product insert.

Instructions

• Store according to the product label and package insert
• Protect from moisture, direct sunlight, high temperature, and contamination
• Do not use expired test devices
• Do not use damaged or opened pouches
• Keep sealed until use
• Interpret results within the stated reading window
• Dispose of used materials according to laboratory safety rules

Instructions

• For professional in vitro diagnostic use only
• Not intended for home use
• Not intended to diagnose overdose or poisoning
• Not a substitute for clinical evaluation
• Positive results are preliminary unless confirmed
• Negative results do not replace medical judgment
• Use confirmatory testing where clinical, legal, or institutional decisions require it
• Always follow local laboratory, occupational, and regulatory guidelines

LARKSOIS Pharma focuses on reliable diagnostic solutions for global healthcare providers, laboratories, distributors, and institutional screening programs. The Acetaminophen (ACE) Rapid Test Device is developed for professional environments where speed, clarity, and dependable screening support are important.

Advantages

• Urine-based rapid screening format
• 500 ng/mL cut-off level
• Supports toxicology and drug monitoring workflows
• Suitable for professional laboratory use
• Fast preliminary screening support
• Useful for hospitals, clinics, and diagnostic centers
• Designed for international healthcare markets
• Helps support responsible screening and reporting systems